auto-injectors for glp-1 delivery New Diabetes Pill Shows Major Weight Loss and Blood Sugar Control in Clinical Trial MetabolixMD - Home

It has also been prescribed off-label for weight loss for its ability to increase levels of what researchers call an anti-hunger molecule

The capacity of these drugs to increase insulin secretion and suppress glucagon release leads not only to better blood sugar control but also to a better cardiovascular profile, putting them in a favorable position in the treatment of type 2 diabetes

Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin

Chang TT, Liaw YF, Wu SS, et al